Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2022 ∙ Mardiyan Kurniawati, E. Rahmawati, N. A.

Records of antibodies in breast milk in postpartum women who have been vaccinated or exposed to COVID-19: A systematic review

  • Parents/caregivers
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Puig-Barbera, J. Tamames-Gomez, S. Plans-Rubio, P. Eiros-Bouza, J. M.

Relative Effectiveness of Cell-Cultured versus Egg-Based Seasonal Influenza Vaccines in Preventing Influenza-Related Outcomes in Subjects 18 Years Old or Older: A Systematic Review and Meta-Analysis

  • Adults
  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2022 ∙ Zhang, J. Cao, J. Ye, Q.

Renal Side Effects of COVID-19 Vaccination

  • Adolescents
  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Lane, S. Yeomans, A. Shakir, S.

Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature

  • Adolescents
  • Adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Parker, E. P. K. Desai, S. Marti, M. Nohynek, H. Kaslow, D. C. Kochhar, S. O'Brien, K. L. Hombach, J. Wilder-Smith, A.

Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review

  • Adults
  • Older adults
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Kroon, F. P. B. Najm, A. Alunno, A. Schoones, J. W. Landewe, R. B. M. Machado, P. M. Navarro-Compan, V.

Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations

  • All age groups
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Tsiorou, K. Sarantaki, A.

Risk Assessment of COVID-19 Vaccination Among Childbearing Women

  • Adults
  • Adolescents
  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2022 ∙ Petrá M Janovská, D. Čelko, A. M. D Selinger, E. Dole Neradov Franklová, M. Dlouhý, P. Rosina, J. Lesná, I. K.

Risk factors affecting COVID-19 vaccine effectiveness identified from 290 cross-country observational studies until February 2022: a meta-analysis and meta-regression

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2022 ∙ Boender, T. S. Bartmeyer, B. Coole, L. Wichmann, O. Harder, T.

Risk of Guillain-Barré syndrome after vaccination against human papillomavirus: A systematic review and meta-analysis, 1 January 2000 to 4 April 2020

  • Adolescents
  • Adults
  • Older adults
  • Human papillomavirus (HPV)
  • Safety
Methodological quality (AMSTAR 2):
High
2022 ∙ Dzinamarira, Tafadzwa Murewanhema, Grant Chitungo, Itai Ngara, Bernard Nkambule, Sphamandla Josias Madziva, Roda Herrera, Helena Mukwenha, Solomon Cuadros, Diego F. Iradukunda, Patrick Gad Mashora, Moreblessing Tungwarara, Nigel Rwibasira, Gallican Nshogoza Musuka, Godfrey

Risk of mortality in HIV-infected COVID-19 patients: A systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...